Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2001-4-5
pubmed:abstractText
This study was performed to investigate the association between human leukocyte antigen (HLA) and susceptibility to sudden sensorineural hearing loss in the Korean population. HLA-A and HLA-B typing using a standard microlymphocytotoxicity technique and HLA-DRB1 genotyping were performed in 35 patients with sudden sensorineural hearing loss and in 206 healthy controls. Prednisone (usual dose 60 mg/day) was administered for 6 days and tapered for an additional 4-6 days. Both initial hearing levels at the onset of deafness and final hearing levels after treatment were examined and evaluated for association with HLA alleles. The frequency of HLA-DRB1*14 was increased in patients with sudden sensorineural hearing loss compared with controls (relative risk [RR] = 2.7, p = 0.016). The frequencies of HLA-A2, -A31, -B52, -B61, -DRB1*04, -DRB1*11 and -DRB1*12 were slightly higher than in the controls, but did not reach statistical significance. When an association between the treatment results and HLA alleles was also evaluated, the frequency of HLA-DRB1*04 was found to be increased in the patients who did not respond to steroid treatment compared with both patients who responded well to steroid (50%, vs 16%, p = 0.034) and controls (RR = 3.0, p = 0.046). These results suggest that there is an association between HLA-DRB1*14 and disease susceptibility and that the presence of HLA-DRB1*04 may be an useful marker for predicting a poor prognosis in Korean patients with sudden sensorineural hearing loss.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0001-6489
pubmed:author
pubmed:issnType
Print
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
710-5
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11099146-Adult, pubmed-meshheading:11099146-Aged, pubmed-meshheading:11099146-Anti-Inflammatory Agents, pubmed-meshheading:11099146-Audiometry, Pure-Tone, pubmed-meshheading:11099146-Female, pubmed-meshheading:11099146-Gene Frequency, pubmed-meshheading:11099146-Genetic Predisposition to Disease, pubmed-meshheading:11099146-Genotype, pubmed-meshheading:11099146-HLA-A Antigens, pubmed-meshheading:11099146-HLA-B Antigens, pubmed-meshheading:11099146-HLA-DR Antigens, pubmed-meshheading:11099146-HLA-DRB1 Chains, pubmed-meshheading:11099146-Hearing Loss, Sudden, pubmed-meshheading:11099146-Humans, pubmed-meshheading:11099146-Korea, pubmed-meshheading:11099146-Male, pubmed-meshheading:11099146-Middle Aged, pubmed-meshheading:11099146-Prednisone, pubmed-meshheading:11099146-Recovery of Function, pubmed-meshheading:11099146-Severity of Illness Index
pubmed:year
2000
pubmed:articleTitle
Distribution of HLA-A, -B and -DRB1 alleles in patients with sudden sensorineural hearing loss.
pubmed:affiliation
Department of Otolaryngology, Kangnam St. Mary's Hospital, The Catholic University of Korea, College of Medicine, Seoul, South Korea. swyeo@cmc.cuk.ac.kr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't